Make us your home page
Instagram

Today’s top headlines delivered to you daily.

(View our Privacy Policy)

Scientists work on manipulating Alzheimer's gene

The gene for apolipoprotein E4, or ApoE4, confers the largest known genetic risk for Alzheimer's disease, but that's not all. People who carry the gene also do much worse if they develop multiple sclerosis, Lou Gehrig's disease, Parkinson's disease, sleep apnea and other forms of dementia. They don't recover as well from traumatic brain injury or stroke. They are more likely to develop "pump head" — a combination of memory problems and mental fogginess — if they have heart bypass surgery. People with sleep apnea, who stop breathing many times during the night, tend to develop more memory and thinking problems if they carry the gene for ApoE4.

On top of that, problems caused by ApoE4 don't wait until old age. Effects have been detected much earlier in life. A recent paper in JAMA Neurology even reported that ApoE4 babies display brain changes that could contribute to Alzheimer's disease later in life.

Why would a gene that contains instructions for assembling the ApoE4 protein, which transports fats, cholesterol and other substances around the body, cause so much trouble? And why don't the genes for the ApoE2 and ApoE3 proteins — the two other forms of the protein in humans — cause the same problems?

Robert Mahley, who has studied cholesterol and the ApoE protein for decades, says the problem lies in one tiny difference that sets ApoE4 apart from the other two variations. And he believes this difference can be corrected, which would eliminate the vulnerability to brain dysfunction that ApoE4 carriers now face.

The ApoE protein consists of 299 amino acids linked like pearls on a coil. Most of the coil folds into a large domain that resembles the palm of a hand with the four fingers held tightly together. The other domain resembles the thumb extended away from the palm.

In ApoE2 and ApoE3, the "thumb" remains comfortably apart from the "hand," according to Dr. Mahley, president emeritus of the Gladstone Institutes in San Francisco. The ApoE4 protein, however, possesses a different amino acid in one position that causes the thumb to stick to the hand. When the two domains stick together, the protein folds inappropriately, getting broken down by brain cells for recycling or elimination. The resulting fragments tend to accumulate in the cells, causing stress that contributes to their death.

Mahley and Yadong Huang, his longtime collaborator at Gladstone, believe they have a way of fixing this problem. In a paper published in 2012 they described a "structure corrector" known as PY-101 capable of preventing the thumb of the ApoE4 protein from sticking to the hand. This makes ApoE4 essentially identical to ApoE3, which carries no additional risk for Alzheimer's disease.

"We can change structure of E4 to make it E3-like, and in so doing we correct the detrimental effects ApoE4 has in mouse models," Mahley said.

Now Gladstone researchers are trying to develop a pill that will do the same in humans, and Mahley predicts human clinical trials may begin within two years. To help advance the idea the Wellcome Trust recently bestowed a $2.5 million "Seeding Drug Discovery Award" on Dr. Mahley and his colleagues, and they have formed a partnership with a drug design firm located near San Francisco to develop a structure corrector in pill form that will prevent human ApoE4 from misfolding.

"We've already proven that PY-101 gets into the brain, so we're trying to develop a formulation that's orally available," he said. "We're working that out in our mice right now."

Tom Valeo writes on health matters. He can be reached at tom.valeo@gmail.com.

Scientists work on manipulating Alzheimer's gene 03/21/14 [Last modified: Wednesday, March 19, 2014 12:51pm]
Photo reprints | Article reprints

© 2017 Tampa Bay Times

    

Join the discussion: Click to view comments, add yours

Loading...
  1. Nearly 1 in 4 Tampa Bay homeowners considered equity rich

    Real Estate

    If your home is worth at least 50 percent more than you owe, you're rich — equity rich that is.

    About one in four Tampa Bay homeowners are considered "equity rich." [Associated Press file photo]
  2. Trump strategist Steve Bannon: No military solution in North Korea

    National

    BRIDGEWATER, N.J. — President Donald Trump's chief strategist Steve Bannon says there's no military solution to the threat posed by North Korea and its nuclear ambitions, despite the president's recent pledge to answer further aggression with "fire and fury."

    Steve Bannon, chief White House strategist to President Donald Trump, has drawn fire from some of Trump's closest advisers. [Associated Press]
  3. Rays have their chances, but end up with another loss (w/video)

    The Heater

    TORONTO — The litany of games the Rays have given away this season is long enough, arguably too lengthy. So the only way to get to the postseason is make up for some of those losses by grabbing some wins when the opportunity is presented, especially at this time of year when the margin is diminished and the stakes …

    Associated Press
  4. Dunedin man accused of possessing child pornography

    Crime

    DUNEDIN — A 57-year-old man was arrested Wednesday, accused of intentionally downloading child pornography, the Pinellas County Sheriff's Office said.

    Richard Beal Anger, 57, of Dunedin faces 11 counts of possession of child pornography. [Courtesy of the Pinellas County Sheriff's Office]
  5. Pence cuts short Latin America trip and pressures Chile to sever all ties to North Korea

    Politics

    SANTIAGO, Chile — Vice President Mike Pence is cutting short his Latin America trip by one day to return to Washington for a strategy meeting Friday at Camp David with President Donald Trump and the national security team.

    Vice President Mike Pence urged Chilean President Michelle Bachelet to take a tougher stand against North Korea on Wednesday in Santiago, Chile.